Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Deutsche Bank Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Tipranks - Thu Feb 26, 5:40AM CST

Deutsche Bank analyst Falko Friedrichs maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €44.00.

Claim 50% Off TipRanks Premium

According to TipRanks, Friedrichs is an analyst with an average return of -2.7% and a 40.38% success rate. Friedrichs covers the Healthcare sector, focusing on stocks such as Siemens Healthineers AG, SCHOTT Pharma AG & Co. KGaA, and Fresenius Medical Care AG & Co. KGaA.

In addition to Deutsche Bank , Fresenius Medical Care AG & Co. KGaA also received a Hold from Barclays’s Hassan Al-Wakeel in a report issued yesterday. However, on the same day, Bank of America Securities maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).

0H9X market cap is currently €11.12B and has a P/E ratio of 12.32.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.